Beckman Coulter, BD, GeneOhm

Premium

Beckman Coulter's Q4 Revenues Fall 5.4 Percent as Income Drops 70 Percent

Beckman Coulter reported this week that its fourth-quarter sales fell by 5.4 percent to $655.5 million from $693 million during the year-ago period.

Fourth-quarter consumable sales were up 12 percent, with acquisitions contributing to 3.9 percent of that growth.

Net income for the period decreased 70 percent to $17.8 million from $59.8 million during the fourth quarter of 2004.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.